Chengdu Kanghua Biological Products (300841) — Cash Flow Reinvestment Rate
Chengdu Kanghua Biological Products (300841) has a Cash Flow Reinvestment Rate of 0.16x as of September 2025, reinvesting CN¥14.49 Million (capex CN¥14.49 Million ) from operating cash flow of CN¥92.89 Million. Explore 300841 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Chengdu Kanghua Biological Products Cash Flow Reinvestment Rate (2015–2024)
Historical reinvestment intensity for Chengdu Kanghua Biological Products across 10 annual periods. Also explore Chengdu Kanghua Biological Products total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Chengdu Kanghua Biological Products (2015–2024)
Year-by-year capital reinvestment analysis for Chengdu Kanghua Biological Products. For live market cap and broader valuation context, see Chengdu Kanghua Biological Products (300841) total market value.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.60x | CN¥342.14 Million | CN¥572.24 Million | CN¥144.30 Million | ▲ +7.0% |
| 2023 | 0.56x | CN¥320.66 Million | CN¥573.98 Million | CN¥157.27 Million | ▼ -74.4% |
| 2022 | 2.18x | CN¥425.48 Million | CN¥194.99 Million | CN¥419.23 Million | ▼ -32.9% |
| 2021 | 3.25x | CN¥423.69 Million | CN¥130.33 Million | CN¥314.94 Million | ▲ +170.8% |
| 2020 | 1.20x | CN¥443.67 Million | CN¥369.56 Million | CN¥135.67 Million | ▼ -33.9% |
| 2019 | 1.82x | CN¥332.04 Million | CN¥182.73 Million | CN¥24.04 Million | ▼ -69.6% |
| 2018 | 5.97x | CN¥342.58 Million | CN¥57.35 Million | CN¥34.58 Million | ▲ +71.9% |
| 2017 | 3.47x | CN¥312.53 Million | CN¥89.96 Million | CN¥4.53 Million | ▲ +147.5% |
| 2016 | 1.40x | CN¥3.71 Million | CN¥2.64 Million | CN¥1.86 Million | ▲ +197.4% |
| 2015 | 0.47x | CN¥3.07 Million | CN¥6.51 Million | CN¥3.07 Million | — |